Dopaminergic Neuron-Specific Tfam Knockout Links Inter-Organelle Miscommunication to Early-Onset Parkinsonism

Weiyan Shen1,2,3, Mengling Zheng1, Yanlin Zhao1

  • 1Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Zhejiang Key Laboratory of Medical Epigenetics, Hangzhou Normal University, Hangzhou, China.

Insights

Mitochondrial transcription factor A (TFAM) deficiency causes early-onset Parkinson's disease (PD) symptoms in mice. Inhibiting mitophagy or blocking cGAS-cGAMP-TBK1 signaling partially reduces neuroinflammation but does not fully rescue PD progression or survival.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Parkinson's disease (PD) involves mitochondrial dysfunction and dopaminergic neuron loss.
  • Early-onset PD subtypes are underrepresented, and the role of mitochondrial instability needs clarification.

Purpose of the Study:

  • To investigate how mitochondrial transcription factor A (TFAM) deficiency impacts early-onset PD pathogenesis using a mouse model.
  • To explore the role of inter-organelle communication and inflammatory pathways in PD.

Main Methods:

  • Utilized a dopaminergic neuron-specific Tfam conditional knockout (cKO) mouse model.
  • Assessed motor deficits, α-synuclein accumulation, TH+ neuronal loss, and lifespan.
  • Analyzed mitochondrial function (mtDNA, respiration, NAD+/NADH, membrane potential), ER stress, and transcriptomic profiles.
  • Investigated the impact of mitophagy inhibition and cGAS pathway modulation.

Main Results:

  • Tfam cKO mice exhibited progressive motor deficits, α-synuclein accumulation, and dopaminergic neuron loss by 2 months.
  • Mitochondrial dysfunction hallmarks (mtDNA depletion, impaired respiration, altered ratios, ER stress) were observed.
  • Transcriptomic analysis revealed downregulated nAChR subunits and upregulated ribosomal genes, indicating disrupted inter-organelle communication.
  • Mitophagy inhibition exacerbated neurodegeneration; cytosolic mtDNA leakage activated the cGAS-cGAMP-TBK1 axis, increasing neuroinflammation.
  • Genetic cGAS ablation reduced neuroinflammation and delayed behavioral decline but did not rescue mitochondrial defects or survival.

Conclusions:

  • Tfam cKO mice serve as a valuable model for studying early-onset PD pathogenesis linked to inter-organelle miscommunication.
  • Targeting the cGAS pathway can attenuate neuroinflammation in this PD model, but it does not fully address the core PD symptoms or improve lifespan.